Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Holdings Inc Aventis currently holds 3,811,071 shares of INTROGEN THERAPEUTICS INC (INGN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Holdings Inc Aventis has been a net seller of INGN stock. They have purchased $0 and sold $1.4M worth of shares.
Holdings Inc Aventis's most recent insider trade was on Aug 30, 2006, when they sold 10,500 shares at $3.96 per share.
Holdings Inc Aventis serves as Executive at INTROGEN THERAPEUTICS INC (INGN). They have executed 10 insider transactions totaling $1.4M over their tenure at the company.
Holdings Inc Aventis holds the position of Executive at INTROGEN THERAPEUTICS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Holdings Inc Aventis has shown a selling trading pattern, with $0 in total purchases and $1.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Holdings Inc Aventis was on Mar 16, 2006, when they sold $448.4K worth of INGN shares. This transaction involved 82,434 shares at $5.44 per share.
Holdings Inc Aventis currently owns 3,811,071 shares of INTROGEN THERAPEUTICS INC (INGN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Holdings Inc Aventis's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Holdings Inc Aventis has 10 Form 4 filings on record as an insider at INTROGEN THERAPEUTICS INC.
Set alerts for Holdings Inc Aventis and 40,000+ other insiders.